Whole Section

  • 8.2A Closing Price of Prescribed Instrument

    • 8.2A.2

      The closing price of a Prescribed Instrument shall be determined in accordance with the relevant formula and procedures applicable to each Prescribed Security, as determined by SGX-ST from time to time. In arriving at such formula and procedure, SGX-ST may take into account factors, including but not limited to:

      (1) the last traded price;
      (2) prevailing bids and offers during the trading phase and/or closing routine; and/or
      (3) price data derived from pricing models, as selected or established by SGX-ST from time to time.

      Refer to Practice Note 8.2A.2.

      Added on 24 February 201424 February 2014 and amended on 8 October 20188 October 2018.

    • 8.2A.4

      Without limiting Rule 2.4.1, SGX-ST (including SGX-ST's subsidiaries, related companies and holding company), its Directors, Officers, employees and agents make no warranty, express or implied, and shall have no liability to any person in respect of, or in connection with, the closing price of a Prescribed Security, including without limitation:

      (1) the accuracy, reliability or timeliness of the closing price of a Prescribed Security;
      (2) the merchantability and fitness of the closing price of a Prescribed Security for a particular purpose;
      (3) any direct, special, punitive, indirect or consequential damages (including lost profits) in relation to use of or reliance on the closing price of a Prescribed Security, even when notified of the possibility of such damages; and/or
      (4) any errors, omissions or delays in calculating, determining or disseminating the closing price of a Prescribed Security.

      Added on 24 February 201424 February 2014.